<table sstyle="width:80%" align="center" border=1>
<tr>
<th>mv</th>
<th>dw</th>
<th>HMMCrowd</th>
</tr>
<tr>
<td width=33%>
[9, 10] erythropoietin<br>[31, 32] epoetin<br>[58, 60] epoetin alfa<br>[72, 74] epoetin alfa<br>[82, 84] epoetin alfa<br></td>
<td width=33%>
[9, 10] erythropoietin<br>[21, 23] epoetin alfa<br>[31, 33] epoetin alfa<br>[54, 63] three weekly doses of epoetin alfa 40,000 U subcutaneously<br>[72, 74] epoetin alfa<br>[82, 84] epoetin alfa<br>[305, 307] epoetin alfa<br></td>
<td width=33%>
[9, 10] erythropoietin<br>[21, 23] epoetin alfa<br>[31, 33] epoetin alfa<br>[54, 75] three weekly doses of epoetin alfa 40,000 U subcutaneously (SC), followed by either standard weekly epoetin alfa (<br>[80, 85] U of epoetin alfa (<br>[86, 89] arm) SC<br>[128, 130] arm.<br>[305, 307] epoetin alfa<br>[339, 342] epoetin alfa.<br></td>
</tr>
